UBS Group’s Coya Therapeutics COYA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $87K | Sell |
15,127
-18,962
| -56% | -$109K | ﹤0.01% | 6079 |
|
2025
Q1 | $221K | Sell |
34,089
-8,937
| -21% | -$57.8K | ﹤0.01% | 5247 |
|
2024
Q4 | $247K | Buy |
+43,026
| New | +$247K | ﹤0.01% | 5136 |
|
2024
Q3 | – | Sell |
-10,696
| Closed | -$64.8K | – | 8322 |
|
2024
Q2 | $64.8K | Buy |
10,696
+10,096
| +1,683% | +$61.2K | ﹤0.01% | 5338 |
|
2024
Q1 | $5.95K | Sell |
600
-1,879
| -76% | -$18.6K | ﹤0.01% | 6323 |
|
2023
Q4 | $18.4K | Buy |
+2,479
| New | +$18.4K | ﹤0.01% | 5949 |
|
2023
Q3 | – | Sell |
-26,602
| Closed | -$108K | – | 8341 |
|
2023
Q2 | $108K | Buy |
26,602
+23,756
| +835% | +$96.7K | ﹤0.01% | 4901 |
|
2023
Q1 | $11.3K | Buy |
2,846
+1,631
| +134% | +$6.48K | ﹤0.01% | 6423 |
|
2022
Q4 | $5.76K | Buy |
+1,215
| New | +$5.76K | ﹤0.01% | 7937 |
|